Validation of the Hebrew Version of the Montreal Affective Voices.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Today, no non-verbal auditory stimuli that assess mental processing are available in Israel. The goal of this study is to make available a validated set of auditory stimuli in Israel. We created a computerized Hebrew version of the Montreal Affective Voices (MAV). The MAV is a novel tool for assessing mental processing. The MAV consists of 90 nonverbal affect bursts corresponding to nine different emotions (such as anger, fear, happiness etc.) recorded by ten different actors. The uniqueness of these affective bursts is that they do not contain verbal context, but rather express affective moods using the vowel /a/ (as in "apple"). In this study, the investigators will verify the new Hebrew version of MAV in healthy control groups. Next, the investigators will compare the mental processing ability in young vs. old population, using the MAV test. In addition, the investigators will assess mental processing in two pathologic study groups (Parkinson's disease, major depressive disorder) using the MAV test. The investigators intend to use the MAV tool in future research in Parkinson's disease and depression.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Development and Validation of a Novel Functional Eye-Tracking Software Application for Neurological Disorders

NCT05212727

Neurological Disorders

SUSPENDED

Examining the Efficiency of Neurofeedback Therapy on Adults With Sensory Over Responsivity

NCT03837795

Sensory Modulation Disorder Sensory Over-Responsivity

COMPLETED NA

Electroencephalography Based Neurofeedback in Chronic Neuropathic Pain

NCT01560039

Neuropathic Pain

UNKNOWN NA

Compensatory Brain Mechanisms for Amygdala-associated Cognitive Dysfunction: Potential Role of the Cortical Mirror Neuron System

NCT03723733

Healthy

UNKNOWN

Brain Correlates of Visual Processing of Emotional Scenes in ACTion and EMOtional Judgments During Normal VIeillissement

NCT03969043

Aging

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson's Disease Depression

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

healthy control group

Young (20-49) and Older (50-70) healthy group (n=60)

No interventions assigned to this group

Parkinson's disease patients

(n=30).

No interventions assigned to this group

Major depressive disorder patients

(n=30).

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy group
* Parkinson's disease
* Major depressive disorder
* All participants will be competent and willing to give written informed consent. Patients over 65 and/or suspected to have a cognitive decline will be tested by the Mini-mental test and will be included in the study only if the score is above 26.